Your browser doesn't support javascript.
loading
Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis.
Ma, Yushan; Wang, Jierui; Guo, Shuo; Meng, Zirui; Ren, Yan; Xie, Yi; Wang, Minjin.
Afiliação
  • Ma Y; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Wang J; Department of Laboratory Medicine, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
  • Guo S; Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
  • Meng Z; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Ren Y; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Xie Y; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Wang M; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
Front Immunol ; 13: 1064007, 2022.
Article em En | MEDLINE | ID: mdl-36761173
ABSTRACT

Objectives:

To summarize the cytokine/chemokine levels of anti-N-methyl-Daspartate receptor encephalitis (NMDAR-E) and explore the potential role of these molecules and immune cells in the pathogenic mechanism.

Methods:

The PubMed, Cochrane Library, Embase, and Web of Science databases were searched for various articles that assessed the concentrations of cytokines/chemokines in the unstimulated cerebrospinal fluid (CSF) or serum of patients with NMDAR-E in this systematic review and meta-analysis. The standardized mean difference (SMD) and 95% confidence interval (CI) were calculated by Stata17.0.

Results:

A total of 19 articles were included in the systematic review from 260 candidate papers, and cytokine/chemokine levels reported in the CSF/serum were examined in each article. This meta-analysis included 17 eligible studies comprising 579 patients with NMDAR-E, 367 patients with noninflammatory neurological disorders, and 42 healthy controls from China, Spain, South Korea, Australia, Czechia, and Sweden. The results indicated that the levels of different cytokines interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-10, IL-13, IL-1ß, IL-12, and IL-17 and chemokine C-X-C motif ligand (CXCL)10 in the CSF were significantly higher in NMDAR-E patients with a large effect size. In addition, B cell activating factor (BAFF), CXCL13, and interferon (IFN)-γ levels in the CSF were higher in NMDAR-E patients with a middle effect size. In contrast, levels of IL-2 and IL-4 in the CSF and CXCL13 and BAFF in the serum did not show a significant difference between cases and controls.

Conclusions:

These analyses showed that the central immune response in NMDAR-E is a process that involves multiple immune cell interactions mediated by cytokines/chemokines, and T cells play an important role in the pathogenesis of immunity. Systematic review registration https//www.crd.york.ac.uk/PROSPERO/, identifier (CRD42022342485).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Quimiocinas / Encefalite Antirreceptor de N-Metil-D-Aspartato Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Quimiocinas / Encefalite Antirreceptor de N-Metil-D-Aspartato Idioma: En Ano de publicação: 2022 Tipo de documento: Article